QUESTIONS ABOUT INHALED BETA-2-ADRENOCEPTOR AGONISTS IN ASTHMA

被引：67

作者：

BARNES, PJ

CHUNG, KF

机构：

[1] Department of Thoracic Medicine, National Heart and Lung Institute, London, SW3 6LY, Dovehouse Street

[2] in the Department of Thoracic Medicine, National Heart and Lung Institute, London, SW3 6LY, Dovehouse Street

来源：

TRENDS IN PHARMACOLOGICAL SCIENCES | 1992年 / 13卷 / 01期

关键词：

D O I：

10.1016/0165-6147(92)90011-T

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The safety of the most widely prescribed antiasthma drugs, beta(2)-adrenoceptor agonists, has recently been questioned. Issues such as their suitability for long-term and regular prophylactic use are addressed in this Comment article by Peter Barnes and Fan Chung, who examine the possibility that the beta(2)-agonists themselves contribute to worsening symptoms in asthma patients, thus setting up a vicious circle with greater use of the drugs. They conclude that it would be prudent to restrict the use of beta(2)-agonists in asthma to on-demand immediate symptom control.

引用

页码：20 / 23

页数：4

共 42 条

[1]

AGE CP, 1991, LANCET, V337, P717

[2]

ANDERSON SD, 1976, AM REV RESPIR DIS, V114, P493

[3]

BARNES PJ, 1989, NEW ENGL J MED, V321, P1517

[4] NEW CONCEPTS IN THE PATHOGENESIS OF BRONCHIAL HYPERRESPONSIVENESS AND ASTHMA [J].